DRI-C21041
DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC50 of 0.31 μM. DRI-C21041 inhibits the immune response induced by alloantigen[1].
Product Specifications
CAS Number
2101765-78-8
UNSPSC
12352005
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dri-c21041.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=C2C(NC(C3=CC=C(C4=CC=C(NC(C5=CC=C([N+]([O-])=O)C=C5)=O)C=C4)C=C3)=O)=CC=CC2=CC=C1)(O)=O
Molecular Formula
C30H21N3O7S
Molecular Weight
567.57
References & Citations
[1]Lu H, et, al. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020 Sep 23;5 (1) :213.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TNFRSF5/CD40
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882092-100 1x 100 µL
P53 Tumor Suppressor Protein (TP53/2092R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details